Investor AB (publ)
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Investor AB is a Swedish industrial holding company primarily engaged in long-term active investment across diverse sectors. Its operations are divided into three business segments: Listed Core Investments, Patricia Industries, and Investments in EQT. The Listed Core Investments segment holds significant minority stakes in publicly listed companies such as ABB, AstraZeneca, Atlas Copco, Electrolux, Ericsson, Husqvarna, Nasdaq, Saab, SEB, Sobi, and Wärtsilä. Patricia Industries consists of wholly owned subsidiaries and financial investments, including companies like Aleris, BraunAbility, Laborie, Mölnlycke Health Care, Permobil, The Grand Group, and Vectura, operating across healthcare, industrials, and other sectors. The EQT segment includes Investor’s holdings in the private equity firm EQT AB. Founded in 1916, Investor AB is headquartered in Stockholm, Sweden, and serves markets globally, including Europe and the U.S. Recent major company developments include the acquisition of American medical equipment maker Nova Biomedical for USD 2.2 billion via Patricia Industries’ subsidiary Advanced Instruments, creating an expanded medical instrument manufacturing platform. Investor AB also increased its stakes in major listed companies, acquiring SEK 0.5 billion worth of Ericsson shares, increasing its ownership to 9.9%, and SEK 0.6 billion in Atlas Copco, raising its stake to 17.1%. The company entered into an agreement to divest 5 million shares in SEB, expecting to realize proceeds in the fourth quarter of 2025. Investor AB reported strong financial performance, with an adjusted net asset value reaching SEK 1,028 billion at the end of September 2025 and total shareholder return of 5% for the third quarter, outpacing the main index. Strategic focus remains on cost efficiency and future-proofing its portfolio companies in a challenging global trade environment. Investor AB’s industry footprint encompasses pharmaceuticals, telecommunications, industrial manufacturing, healthcare products, and financial services. The company’s investment approach involves active ownership and board participation to foster performance improvements. Its diverse portfolio includes engineering, biopharmaceuticals, telecommunications equipment, health solutions, and financial institutions, positioning it as one of Sweden’s largest and most valuable publicly traded companies. This comprehensive structure, combined with recent significant acquisitions and portfolio adjustments, underscores Investor AB’s commitment to long-term value creation and strategic growth within varied industrial and financial markets.
Stellantis Presents FaSTLAne 2030 Financial Framework & Targets at Investor Day 2026
Stellantis to Present New Strategic Plan Today at Investor Day 2026
Stellantis to Present Strategic Plan at May 21 Investor Day
Investor AB (publ) (IVSBF) Q4 2025 Earnings Call Transcript
RioCan Real Estate Investment Trust Announces Investor Day and Third Quarter 2025 Earnings Release, Conference Call and Webcast
Investor AB: Better NAV Discounts Are Out There
'Top priority is to grow portfolio of companies,' Investor AB CEO says
Investor AB (publ) (IVSXF) Q2 2025 Earnings Call Transcript
Kartoon Studios to Report Q4 2024 Results Pre-Market on March 31
Pilgrim's Announces $1.5 Billion Special Dividend and Long-term Capital Allocation Strategy
Investor AB: No NAV Angle Even When Ignoring State Of Private Markets
Investor AB (publ) (IVSXF) Q4 2024 Earnings Call Transcript
SEC Charges Multiple Individuals and Entities in Relationship Investment Scams
Greenlight Re Announces Second Quarter 2024 Financial Results
Investor AB (publ) (IVSXF) Q2 2024 Earnings Call Transcript
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors with Losses to Contact the Firm
JPMorgan Chase Raises FY24 Net Interest Income Guidance Amid Economic Caution
Carnival, Royal Caribbean Shares Are Moving Higher: What's Going On?
Norwegian Cruise Line Holdings Stock Is Rising Today: What's Going On?
ICON plc to hold Investor Day Meeting on May 30, 2024